Michael Lundquist Grant to Advance MSA-C Research

Donor Name: National Ataxia Foundation

Reference URL:https://www.ataxia.org/researcher-resources/

The Michael Lundquist Grant to Advance MSA-C Research provides annual funding to independent researchers for projects focused on advancing the treatment and care of individuals affected by multiple system atrophy, cerebellar subtype (MSA-C).

The National Ataxia Foundation (NAF) is a nonprofit organization dedicated to accelerating the development of treatments for ataxia and improving the lives of those affected by the disease, with a strong emphasis on fostering both national and international research collaboration. The Michael Lundquist Grant to Advance MSA-C Research is part of NAF’s Annual Research Grant Program and honors the legacy of Michael Lundquist by supporting innovative research that seeks to improve outcomes for people living with multiple system atrophy, cerebellar subtype (MSA-C).

This grant is awarded annually to independent researchers for outstanding proposals that focus on preclinical, translational, or clinical research directly related to MSA-C. While proposals may include aspects relevant to other forms of ataxia, the primary emphasis must be on MSA-C. Priority is given to projects that accelerate the development of disease-modifying therapies, support clinical trial readiness (including biomarker discovery and validation), develop or improve diagnostic methods, bridge the gap between scientific discovery and therapeutic application, and significantly advance the mechanistic understanding of MSA-C pathogenesis.

Funding for this award is $50,000 USD for a one-year period (September 1, 2027 – August 31, 2028), and may be used for direct research expenses only. Eligible costs include direct salary and/or stipend (up to $25,000), laboratory reagents and consumable supplies, essential equipment (not to exceed 20% of the total budget), animal purchase and care, publication costs (up to $2,500), investigator registration and travel to scientific meetings or collaboration-related site visits (up to $2,000), and patient-related expenses directly tied to the study. Indirect costs, fringe benefits, tuition, relocation, and other unallowable expenses are not permitted.

Applicants must have completed postdoctoral training and hold a full-time appointment as a faculty member, clinical fellow, or senior scientist at an academic institution, nonprofit, or for-profit company. Both U.S. and international researchers are eligible, but individuals who have received any NAF grant within the past two fiscal years, have an active NAF grant under a no-cost extension, or are delinquent with NAF grant reporting requirements are ineligible. Previous recipients of the Michael Lundquist Grant to Advance MSA-C Research are also ineligible. Applicants may not apply for or receive duplicate funding for the same research aims, and only one Letter of Intent (LOI) may be submitted per funding cycle.

For more information, visit National Ataxia Foundation.

Add Ntchito.com to your Homescreen!